Brand names: Terazosin
Pharmacodynamics A. Benign Prostatic Hyperplasia (BPH) The symptoms associated with BPH are related to bladder outlet obstruction, which is comprised of two underlying components: a static component and a dynamic component. The static component is a consequence of an increase in prostate size. Over time, the prostate will continue to enlarge. However, clinical studies have demonstrated that the size of the prostate does not correlate with the severity of BPH symptoms or the degree of urinary obs
Contraindications
8 documented side effects by frequency
No community discussions found for TERAZOSIN yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
9 available comparisons
Dosage Forms
Tablet
Route
Oral